The 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Could Classify Systemic Sclerosis Patients at Earlier Stage: Data from a Chinese EUSTAR Center
- PMID: 27851803
- PMCID: PMC5112860
- DOI: 10.1371/journal.pone.0166629
The 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Could Classify Systemic Sclerosis Patients at Earlier Stage: Data from a Chinese EUSTAR Center
Abstract
Objectives: To evaluate the performance of the 2013 ACR/EULAR classification criteria for systemic sclerosis (SSc) in clinical practice in a Chinese patient cohort, and to compare outcomes with the 1980 ACR criteria.
Methods: Patients clinically diagnosed with SSc between September 2013 and May 2015 were prospectively recruited from the EUSTAR database of the Peking Union Medical College Hospital. Diagnosis of SSc was based on the evaluation of three experienced rheumatologists. Patients diagnosed with other connective tissue diseases were recruited as disease controls. The 1980 ACR and 2013 ACR/EULAR criteria were applied to the cohort, and patients who fulfilled the criteria were classified as definite SSc patients. Sensitivity and specificity were analyzed for the 2013 and 1980 criteria.
Results: A total of 143 SSc patients and 87 patients with other connective diseases were recruited. 41 (28.7%) and 102 (71.3%) cases were diffuse cutaneous SSc and limited cutaneous SSc, respectively. Although the sensitivity of the 2013 criteria (94.4%) exceeded the 1980 criteria (72.7%) (P<0.001), the 1980 and 2013 criteria sets showed no significant difference in specificity (97.7% and 93.1%, respectively, P = 0.278). The sensitivity of the 2013 criteria was significantly higher than the 1980 criteria in some SSc subgroups (e.g., lcSSc, abnormal pattern of nailfold videocapillaroscopy [NVC] and presence of Raynaud's phenomenon [RP]) compared to others.
Conclusions: Relative to the 1980 ACR criteria, in Chinese SSc patients the new 2013 ACR/EULAR criteria had similar specificity and higher sensitivity, especially for patients with mild skin thickening or prominent microvascular diseases.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424. Ann Rheum Dis. 2013. PMID: 24092682
-
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.Arthritis Rheum. 2013 Nov;65(11):2737-47. doi: 10.1002/art.38098. Epub 2013 Oct 3. Arthritis Rheum. 2013. PMID: 24122180 Free PMC article.
-
Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease.J Rheumatol. 2015 Jan;42(1):60-3. doi: 10.3899/jrheum.140047. Epub 2014 Oct 1. J Rheumatol. 2015. PMID: 25274890
-
Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud's phenomenon.Arthritis Res Ther. 2015 Mar 22;17(1):77. doi: 10.1186/s13075-015-0594-5. Arthritis Res Ther. 2015. PMID: 25889905 Free PMC article.
-
Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic.Semin Arthritis Rheum. 2016 Dec;46(3):350-355. doi: 10.1016/j.semarthrit.2016.05.007. Epub 2016 Jun 3. Semin Arthritis Rheum. 2016. PMID: 27373498
Cited by
-
Transforming growth factor-β signaling in systemic sclerosis.J Biomed Res. 2018 Jan 18;32(1):3-12. doi: 10.7555/JBR.31.20170034. J Biomed Res. 2018. PMID: 29353817 Free PMC article.
-
A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis.Clin Rev Allergy Immunol. 2023 Jun;64(3):358-377. doi: 10.1007/s12016-022-08929-x. Epub 2022 Mar 7. Clin Rev Allergy Immunol. 2023. PMID: 35254622 Free PMC article. Review.
-
Comparisons of Anti-dsDNA Antibody Detection Methods by Chemiluminescent Immunoassay and Enzyme-Linked Immunosorbent Assay in Systemic Lupus Erythematosus.Diagnostics (Basel). 2021 Oct 20;11(11):1940. doi: 10.3390/diagnostics11111940. Diagnostics (Basel). 2021. PMID: 34829287 Free PMC article.
References
-
- Zhang X, Zhang FC, Dong Y. Pulmonary hypertension in connective tissue diseases. Chinese Journal of Rheumatology. 1999;1: 5–7.
-
- Zhang X, Dong Y, Zhang FC. Pulmonary interstitial fibrosis in connective tissue diseases. Chinese of Rheumatology.1999;3: 247–248.
-
- Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–590. - PubMed
-
- LeRoy EC, Medsger TA.Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28:1573–1576 - PubMed
-
- Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747–1755. 10.1136/annrheumdis-2013-204424 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical